Better Therapeutics, Inc.
BTTXDelisted May 16, 2024- Industry
- Services-Health Services
- SEC CIK
- 0001832415
Better Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Feb 13, 2024; 22 institutions reported holding it in 13F filings for Q4 2023, worth $281.2K in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 22
- Q4 2023, +4 vs. previous quarter
- 13F value
- $281.2K
- Reported value at the end of Q4 2023
- Superinvestors holding
- 0
- At the end of Q4 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- –
- No comparable prior period
- Net income, FY2022
- -$39.8M
- No comparable prior period
- Free cash flow, FY2022
- -$29.0M
- No comparable prior period
- Revenue, Q3 FY2023
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.03K
- Shares sold short
- Change
- 0
- 0.0% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding BTTX, Q4 2023
Go to the superinvestors tabNo superinvestor reported holding BTTX at the end of Q4 2023.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Better Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Perry David PExecutive Chairman | PPurchase | +1.23M | $0.73 | +$900.1K | +10.5%13.0M after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Berman Mark A.Chief Medical Officer | PPurchase | +54.8K | $0.73 | +$40.0K | +16.4%388.2K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Armanino Andrew J.Director | PPurchase | +274.0K | $0.73 | +$200.0K | +60.3%728.4K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Granger ElderDirector | PPurchase | +34.3K | $0.73 | +$25.0K | +2,140.7%35.9K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Karbe FrankChief Executive Officer | PPurchase | +137.0K | $0.73 | +$100.0K | +46.9%429.4K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Parker Geoffrey M.Director | PPurchase | +685.0K | $0.73 | +$500.1K | +199.7%1.03M after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Granger ElderDirector | PPurchase | +600 | $0.87 | +$522 | +60.0%1.60K after | |
| Apr 12, 2023 (view filing)9:44 PM ET | Apr 10 | 2 days | Perry David P and 1 otherSee Remarks | PPurchase | +4.97M | $0.825 | +$4.10M | New position3.64M after | 2 lots |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Karbe FrankSee Remarks | PPurchase | +242.4K | $0.83 | +$201.2K | +484.8%292.4K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Parker Geoffrey M.Director | PPurchase | +303.0K | $0.83 | +$251.5K | +757.6%343.0K after |
Top 10 13F holders, Q4 2023
See all 22 holdersThe largest institutional positions in Better Therapeutics, Inc. at the end of Q4 2023; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 356,270 | $65.2K | 0.01% | −1,226,809−77.5% | Reduced |
| Citadel Advisors LLC | 216,165 | $42.2K | 0.00% | +189,999+726.1% | Added |
| Vanguard Group Inc | 198,154 | $38.6K | 0.00% | −301,743−60.4% | Reduced |
| Geode Capital Management, LLC | 168,821 | $32.9K | 0.00% | +61,943+58.0% | Added |
| Millennium Management LLC | 128,749 | $25.1K | 0.00% | +91,876+249.2% | Added |
| BlackRock Inc. | 88,635 | $17.3K | 0.00% | −390−0.4% | Reduced |
| Capital Investment Advisory Services, LLC | 71,000 | $13.8K | 0.00% | +30,000+73.2% | Added |
| State Street Corp | 58,600 | $11.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 38,057 | $7.42K | 0.00% | +38,057 | New |
| CI Private Wealth, LLC | 29,180 | $5.69K | 0.00% | +29,180 | New |